Evidence map›Paper›PMID 30995915›Full record

ArticleOrphanet journal of rare diseases2019

Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes.

Elena G Arias-Salgado, Eva Galvez, Lurdes Planas-Cerezales, Laura Pintado-Berninches, Elena Vallespin, Pilar Martinez, Jaime Carrillo, Laura Iarriccio, Anna Ruiz-Llobet, Albert Catalá and 19 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Identification and characterization of novelCold Spring Harbor molecular case studies · 2021
    Article
  19. Article
  20. Germline mutation ofScience advances · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 16 institutions in 1 country.

Elena G Arias-SalgadoInstituto de Investigaciones Biomedicas CSIC/UAM, IDIPaz, Arturo Duperier, 4, 28029, Madrid, Spain.
Eva GalvezHospital Niño Jesús, Hematología y Hemoterapia, Madrid, Spain.
Lurdes Planas-CerezalesILD Unit Pneumology Department, University Hospital of Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain.
Laura Pintado-BerninchesInstituto de Investigaciones Biomedicas CSIC/UAM, IDIPaz, Arturo Duperier, 4, 28029, Madrid, Spain.
Elena VallespinInstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, Madrid, Spain.
Pilar MartinezInstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, Madrid, Spain.
Jaime CarrilloInstituto de Investigaciones Biomedicas CSIC/UAM, IDIPaz, Arturo Duperier, 4, 28029, Madrid, Spain.
Laura IarriccioInstituto de Investigaciones Biomedicas CSIC/UAM, IDIPaz, Arturo Duperier, 4, 28029, Madrid, Spain.
Anna Ruiz-LlobetPediatric Hematology and Oncology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
Albert CataláPediatric Hematology and Oncology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
Isabel Badell-SerraHospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Luis I Gonzalez-GranadoHospital 12 de Octubre, Madrid, Spain.
Andrea Martín-NaldaImmunology Division, Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Mónica Martínez-GalloImmunology Division, Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Ana Galera-MiñarroHospital Universitario Virgen de la Arrixaca, Murcia, Spain.
Carmen Rodríguez-VigilHospital Miguel Servet, Zaragoza, Spain.
Mariana Bastos-OreiroHospital Universitario Gregorio Marañon, IiSGM, Madrid, Spain.
Guiomar Perez de NanclaresMolecular (Epi)Genetics Laboratory, BioAraba National Health Institute, OSI Araba University Hospital, Vitoria-Gasteiz, Spain.
Virginia Leiro-FernándezPneumology Department, Hospital Álvaro Cunqueiro, Complexo Hospitalario Universitario de Vigo, NeumoVigoI+i Research Group, Vigo Biomedical Research Institute (IBIV), Barcelona, Spain.
Maria-Luz UriaImmunology Division, Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Cristina Diaz-HerediaImmunology Division, Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron (HUVH), Vall d'Hebron Research Institute (VHIR), Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Claudia ValenzuelaHospital de La Princesa, Madrid, Spain.
Sara MartínILD Unit Pneumology Department, University Hospital of Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain.
Belén López-MuñizHospital Infanta Leonor, Madrid, Spain.
Pablo LapunzinaInstitute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz, Madrid, Spain.
Julian SevillaHospital Niño Jesús, Hematología y Hemoterapia, Madrid, Spain.
María Molina-MolinaILD Unit Pneumology Department, University Hospital of Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain.
Rosario PeronaInstituto de Investigaciones Biomedicas CSIC/UAM, IDIPaz, Arturo Duperier, 4, 28029, Madrid, Spain.
Leandro SastreInstituto de Investigaciones Biomedicas CSIC/UAM, IDIPaz, Arturo Duperier, 4, 28029, Madrid, Spain. lsastre@iib.uam.es.ORCID 0000-0003-3613-5938
Instituto de Investigaciones Biomédicas Sols-Morreale · ESUniversitat Autònoma de Barcelona · ESBellvitge University Hospital · ESHospital Universitario La Paz · ESHospital Sant Joan de Déu Barcelona · ESCentre for Biomedical Network Research on Rare Diseases · ESHospital de Sant Pau · ESHospital General Universitario Gregorio Marañón · ESHospital Infantil Universitario Niño Jesús · ESHospital Universitario Araba · ESHospital Universitario de La Princesa · ESHospital Universitario Infanta Leonor · ESHospital Universitario Miguel Servet · ESHospital Universitario Virgen de la Arrixaca · ESResearch Institute Hospital 12 de Octubre · ESUniversity Hospital Complex Of Vigo · ES

Funding

Fundación General CSIC TC0000100Instituto de Salud Carlos III PI14-01495Instituto de Salud Carlos III PI17-01401
6 · The paper itself

Abstract

backgroundTelomeres are nucleoprotein structures present at the terminal region of the chromosomes. Mutations in genes coding for proteins involved in telomere maintenance are causative of a number of disorders known as telomeropathies. The genetic origin of these diseases is heterogeneous and has not been determined for a significant proportion of patients.

methodsThis article describes the genetic characterization of a cohort of patients. Telomere length was determined by Southern blot and quantitative PCR. Nucleotide variants were analyzed either by high-resolution melting analysis and Sanger sequencing of selected exons or by massive sequencing of a panel of genes.

resultsForty-seven patients with telomere length below the 10% of normal population, affected with three telomeropathies: dyskeratosis congenita (4), aplastic anemia (22) or pulmonary fibrosis (21) were analyzed. Eighteen of these patients presented known pathogenic or novel possibly pathogenic variants in the telomere-related genes TERT, TERC, RTEL1, CTC1 and ACD. In addition, the analyses of a panel of 188 genes related to haematological disorders indicated that a relevant proportion of the patients (up to 35%) presented rare variants in genes related to DNA repair or in genes coding for proteins involved in the resolution of complex DNA structures, that participate in telomere replication. Mutations in some of these genes are causative of several syndromes previously associated to telomere shortening.

conclusionNovel variants in telomere, DNA repair and replication genes are described that might indicate the contribution of variants in these genes to the development of telomeropathies. Patients carrying variants in telomere-related genes presented worse evolution after diagnosis than the rest of patients analyzed.

Indexed as

AdolescentAdultAnemia, AplasticChildChild, PreschoolDNA RepairDyskeratosis CongenitaExonsFemaleHumansInfantMalePedigreePulmonary FibrosisRNATelomeraseRNATelomerasetelomerase RNATERT protein, humanAplastic anemiaDNA repairDyskeratosis congenitaPulmonary fibrosisTelomereTelomeropathies

Identifiers

PMID30995915
PMCPMC6471801
OpenAlexW2945194311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.